GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
157.88
+7.27 (4.83%)
At close: Oct 28, 2026, 4:00 PM EDT
157.90
+0.02 (0.01%)
After-hours: Oct 28, 2026, 7:59 PM EDT
GRAIL Employees
GRAIL had 910 employees as of December 31, 2025. The number of employees decreased by 90 or 9.00% compared to the previous year. That makes GRAIL the 15,564th largest employer in the world and 2,239th in the United States.
Employees
910
Change (1Y)
-90
Growth (1Y)
-9.00%
Revenue / Employee
$181,608
Profits / Employee
-$430,315
Market Cap
7.05B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 910 | -90 | -9.00% |
| Dec 31, 2024 | 1,000 | -360 | -26.47% |
| Sep 30, 2024 | 1,170 | -190 | -13.97% |
| Dec 31, 2023 | 1,360 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ICON Public Limited Company | 40,100 |
| Charles River Laboratories International | 19,700 |
| Revvity | 11,000 |
| RadNet | 9,276 |
| Qiagen | 5,700 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| CareDx | 765 |
GRAL News
- 1 day ago - GRAIL to Present at the UBS Global Healthcare Conference - PRNewsWire
- 7 days ago - GRAIL to Announce Third Quarter 2026 Financial Results - PRNewsWire
- 15 days ago - Grail price target raised to $180 from $88 at TD Cowen - TheFly
- 16 days ago - Grail price target raised to $120 from $60 at Morgan Stanley - TheFly
- 23 days ago - GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026 - PRNewsWire
- 26 days ago - Grail price target raised to $175 from $105 at UBS - TheFly
- 26 days ago - Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms - Reuters
- 27 days ago - Grail price target raised to $155 from $75 at Guggenheim - TheFly